openPR Logo

Press Releases from Drug Safety Alliance (4 total)

Drug Safety Alliance Quality and Regulatory Affairs Leader Earns International C …

Regulatory Affairs Professionals Society Awards Canadian RAC Distinction to Joe Knight-McKenna (Research Triangle Park, N.C.) Drug Safety Alliance (DSA), a global leader in pharmaceutical safety and pharmacovigilance, is proud to announce that Senior Director, Quality and Regulatory Affairs, Joe Knight-McKenna has earned the Regulatory Affairs Certification, Canadian RAC (CAN) distinction. The certification was awarded to Knight-McKenna (MBA, CQM/OE, CQA, CSQE, RAC/CAN) by the Regulatory Affairs Professionals Society (RAPS) and

Drug Safety Alliance Advocates Proactive Signal Detection

Product Life-Cycle Signal Management Can Help Pharmaceutical Companies Protect Public Health and Product Assets (Research Triangle Park, N.C.) Drug Safety Alliance (DSA) -- a global leader in pharmaceutical safety and pharmacovigilance -- offered details at the recent Seventh Annual International Users Conference in San Francisco, CA on how a well-designed signal management program and select tools can help pharmaceutical companies with early detection of new safety information. In her session, "Pragmatic

Drug Safety Alliance Announces Pharmacovigilance Upgrades

Information Technology Improvements Support Implementation of Enhanced Adverse Event Reporting Software (Research Triangle Park, N.C.) - October 30, 2008 -- Drug Safety Alliance (DSA), a global leader in pharmaceutical safety and pharmacovigilance, today announced major hardware and software upgrades to support the implementation of the new Empirica (TM) Trace adverse event reporting software. The announcement was made as DSA Chief Information Officer Doug Hill presented a case study on the upgrade

National Organization Seeks Drug Safety Alliance’s Expertise

Pharmaceutical Safety Company Shares Insight into European Quality Assurance Regulations (Research Triangle Park, N.C.) – October 7, 2008 -- Drug Safety Alliance (DSA), a global leader in pharmaceutical safety and pharmacovigilance, was invited to share their extensive insight into quality assurance protocols in Europe with the Regulatory Affairs Professionals Society (RAPS) at their annual conference held recently in Boston. Conference presenter Joseph Knight-McKenna (MBA, CQM/OE, CQA, CSQE, RAC), DSA’s senior director,